Castle Biosciences, Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Castle Biosciences, Inc. now
Current reporting with the operating signal separated from the noise.
Castle Biosciences, Inc. (CSTL) Q2 2026 Earnings Call Transcript
Investors are testing whether Castle Biosciences, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Castle Biosciences, Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026
The story matters when it changes Castle Biosciences, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Castle Biosciences, Inc. (CSTL) reports Q2 loss, tops revenue estimates
Investors are testing whether Castle Biosciences, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Castle Biosciences, Inc.: Castle Biosciences Reports Second Quarter 2026 Results
The story matters when it changes Castle Biosciences, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Castle Biosciences, Inc. (CSTL) Reports Q4 Loss, Beats Revenue Estimates
Investors are testing whether Castle Biosciences, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Castle Biosciences, Inc. (CSTL) Reports Next Week: Wall Street Expects Earnings Growth
Investors are testing whether Castle Biosciences, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Latest CSTL filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Castle Biosciences, Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →